A survey of the treatment of female patients with osteoporosis using drug utilization consumption parameters

Journal of Clinical Pharmacy and Therapeutics

Volumn 24, Issue 3, 1999, Pages 209-217

  Truter, Ilse ^a,b   Serfontein, J H P ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

^b NELSON MANDELA METROPOLITAN UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCIUM;

ADULT; AGE; AGED; ARTICLE; DIET SUPPLEMENTATION; DRUG COST; DRUG UTILIZATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PRESCRIPTION; SOUTH AFRICA;

AGED; DRUG COSTS; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; SOUTH AFRICA;

EID: 0032838229     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.1999.00222.x     Document Type: Article

References (17)

1. Bilezikian JP. (1996) Current and future nonhormonal approaches to the treatment of osteoporosis. International Journal of Fertility and Menopausal Studies, 41(2), 148-155.
2. Patel S. (1996) Current and potential future drug treatments for osteoporosis. Annals of the Rheumatic Diseases, 55, 700-714.
3. Rowe R. (1996) Osteoporosis care - the need for a district-wide approach. British Journal of Clinical Practice, 50(6), 342-343.
4. Consensus Development Conference. (1993) Diagnosis, prophylaxis and treatment of osteoporosis. American Journal of Medicine, 94, 646-650.
5. Johnston CC. (1996) Development of clinical practice guidelines for prevention and treatment of osteoporosis. Calcified Tissue International, 59(Suppl. 1), S30-S33.
6. Anon (1996) Anatomic Therapeutic Chemical (ATC) Classification Index including Defined Daily Doses (DDDs) for Plain Substances. WHO Collaborating Centre for Drug Statistics Methodology, Oslo.
7. Snyman JR, Pope AI (eds). (1997) MIMS. (Monthly Index of Medical Specialities). Times Media Limited, Pretoria, 37 (8).
8. Gibbon CJ, Swanepoel CR (eds). (1991) SAMF. (South African Medicines Formulary). 3rd edn. The Medical Association of South Africa Publications, Cape Town.
9. Bergman U, Popa C, Tomson Y, et al. (1998) Drug utilization 90% - a simple method for assessing the quality of drug prescribing. European Journal of Clinical Pharmacology, 54, 113-118.
10. Sambrook PN. (1996) Osteoporosis. Medical Journal of Australia, 165(6), 332-336.
11. Orwoll ES, Bliziotes M. (1994) Heterogeneity in osteoporosis. Rheumatic Disease Clinics of North America, 20(3), 671-689.
12. Ross PD. (1996) Prediction of fracture risk II: other risk factors. American Journal of the Medical Sciences, 312(6), 260-269.
13. Anon (1996) Managing osteoporosis. Drug and Therapeutics Bulletin, 34(6), 45-48.
14. Lane JM, Riley EH, Wirganowicz PZ. (1996) Osteoporosis: diagnosis and treatment. Journal of Bone and Joint Surgery, 78(4), 618-632.
15. Bellantoni MF. (1996) Osteoporosis prevention and treatment. American Family Physician, 54(3), 986-992.
16. Daly PA. (1995) Office management of osteoporosis: a guide for the primary care provider. Comprehensive Therapy, 21(10), 565-574.
17. Andersen M, Bjerrum L, Wettermark B, Arrhenius L, Gram LF, Bergrman U. (1997) Prescribing pattern of NSAIDs in Denmark and Sweden using the DU90% methodology. European Journal of Clinical Pharmacology, 52(Suppl.), A37.